JPWO2023043923A5 - - Google Patents
Info
- Publication number
- JPWO2023043923A5 JPWO2023043923A5 JP2024516798A JP2024516798A JPWO2023043923A5 JP WO2023043923 A5 JPWO2023043923 A5 JP WO2023043923A5 JP 2024516798 A JP2024516798 A JP 2024516798A JP 2024516798 A JP2024516798 A JP 2024516798A JP WO2023043923 A5 JPWO2023043923 A5 JP WO2023043923A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- haloalkyl
- heterocycloalkyl
- pharmaceutically acceptable
- tautomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163245718P | 2021-09-17 | 2021-09-17 | |
| US63/245,718 | 2021-09-17 | ||
| PCT/US2022/043660 WO2023043923A1 (en) | 2021-09-17 | 2022-09-15 | Cyclic sulfonamide ribonucleotide reductase (rnr) inhibitors and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024534420A JP2024534420A (ja) | 2024-09-20 |
| JPWO2023043923A5 true JPWO2023043923A5 (https=) | 2025-08-07 |
| JP2024534420A5 JP2024534420A5 (https=) | 2025-08-07 |
Family
ID=85603496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024516798A Pending JP2024534420A (ja) | 2021-09-17 | 2022-09-15 | 環状スルホンアミドリボヌクレオチドレダクターゼ（ｒｎｒ）阻害剤およびその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250002486A1 (https=) |
| EP (1) | EP4401728A4 (https=) |
| JP (1) | JP2024534420A (https=) |
| KR (1) | KR20240101555A (https=) |
| CN (1) | CN118434417A (https=) |
| AU (1) | AU2022345092A1 (https=) |
| CA (1) | CA3231660A1 (https=) |
| IL (1) | IL311458A (https=) |
| MX (1) | MX2024003258A (https=) |
| TW (1) | TW202328121A (https=) |
| WO (1) | WO2023043923A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021325905A1 (en) | 2020-08-12 | 2023-04-13 | Boundless Bio, Inc. | Replication stress pathway agent compositions and methods for treating cancer |
| JP2025531147A (ja) * | 2022-09-13 | 2025-09-19 | バウンドレス バイオ，インク． | 環状スルホンアミドリボヌクレオチドレダクターゼ（ｒｎｒ）阻害剤およびその使用 |
| WO2025049814A2 (en) * | 2023-09-01 | 2025-03-06 | Boundless Bio, Inc. | Ribonucleotide reductase (rnr) compositions and methods of use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3466934T (pt) * | 2016-05-31 | 2024-04-30 | Taiho Pharmaceutical Co Ltd | Compostos de sulfonamida ou seus sais como inibidores da ribonucleótido-redutase para o tratamento de cancro |
| US20200405697A1 (en) * | 2017-11-29 | 2020-12-31 | Taiho Pharmaceutical Co., Ltd. | Antitumor Agent |
| MX2020005478A (es) * | 2017-11-29 | 2020-08-27 | Taiho Pharmaceutical Co Ltd | Compuestos de sulfonamida y usos de los mismos. |
| US20220226291A1 (en) * | 2019-05-29 | 2022-07-21 | Taiho Pharmaceutical Co., Ltd. | Combination Treatment of Cancer Using Sulfonamide Compound and Immune Regulator |
| US20240158383A1 (en) * | 2021-03-02 | 2024-05-16 | Boundless Bio, Inc. | Ribonucleotide reductase (rnr) inhibitors and uses thereof |
-
2022
- 2022-09-15 IL IL311458A patent/IL311458A/en unknown
- 2022-09-15 AU AU2022345092A patent/AU2022345092A1/en active Pending
- 2022-09-15 JP JP2024516798A patent/JP2024534420A/ja active Pending
- 2022-09-15 EP EP22870692.5A patent/EP4401728A4/en active Pending
- 2022-09-15 WO PCT/US2022/043660 patent/WO2023043923A1/en not_active Ceased
- 2022-09-15 CA CA3231660A patent/CA3231660A1/en active Pending
- 2022-09-15 US US18/692,503 patent/US20250002486A1/en active Pending
- 2022-09-15 TW TW111134951A patent/TW202328121A/zh unknown
- 2022-09-15 KR KR1020247012612A patent/KR20240101555A/ko active Pending
- 2022-09-15 CN CN202280075394.XA patent/CN118434417A/zh active Pending
- 2022-09-15 MX MX2024003258A patent/MX2024003258A/es unknown